Clinical Trials · NCT05051579
A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 272
- Start date
- Sep 2021
- Locations
- 35 sites, 4 countries
- Primary endpoint
- Percent Change From Baseline in Body Weight in LY3502970 and Placebo